Tara Reilly
Nurse Practitioner · San Francisco, CANPI 1710905104
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.8% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 21.1% — the pattern of someone who eats at a lot of different presentations.
Across 85 payments — averaging $26.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$475
- AbbVie$413
- Pfizer$259
- Lilly USA, LLC$253
- AstraZeneca$154
- Viiv Healthcare Company$152
- plus $541 from 12 others
What the payments were for
- Food & beverage$2,17397%
- Education$733%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 17 | $475 |
| AbbVie | 13 | $413 |
| Pfizer | 10 | $259 |
| Lilly USA, LLC | 11 | $253 |
| AstraZeneca | 6 | $154 |
| Viiv Healthcare Company | 6 | $152 |
| GSK | 5 | $126 |
| Exact Sciences | 4 | $102 |
| Novo Nordisk | 4 | $97 |
| Boehringer Ingelheim | 1 | $33 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $30 |
| Merck | 1 | $29 |
| Kyowa Kirin, Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Amgen | 1 | $23 |
| Napo Pharmaceuticals Inc | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$113
How this compares
$2,246 in reported general payments places this provider in the 85th percentile of 6,779 nurse practitioner providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 12 | $11,900 |
| JardianceEmpagliflozin | 12 | $8,216 |
| Estradiol | 43 | $2,085 |
| Levothyroxine Sodium | 92 | $1,395 |
| Celecoxib | 18 | $1,055 |
| ValacyclovirValacyclovir Hcl | 12 | $767 |
| Atorvastatin Calcium | 113 | $766 |
| Propranolol Hcl ErPropranolol Hcl | 12 | $757 |
| Mirtazapine | 11 | $619 |
| Losartan Potassium | 53 | $584 |
| Rosuvastatin Calcium | 30 | $570 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $467 |
| Amlodipine Besylate | 96 | $435 |
| Fluticasone Propionate | 25 | $421 |
| Omeprazole | 14 | $393 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $97 | $11,90012 claims |
| Boehringer IngelheimJardiance | $33 | $8,21612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,779 nurse practitioner providers in California.
Other nurse practitioner in San Francisco
- Nilofar ZameniSan Francisco$81K
- Kelly MeauxSan Francisco$54K
- Darlene LeeSan Francisco$28K
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$884K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
- Lynsey LakinArcadia$540K
- Kelly ChoiRancho Cucamonga$483K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.